BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yao Q, Xing Y, Wang Z, Liang J, Lin Q, Huang M, Chen Y, Lin B, Xu X, Chen W. MiR-16-5p suppresses myofibroblast activation in systemic sclerosis by inhibiting NOTCH signaling. Aging (Albany NY) 2020;13:2640-54. [PMID: 33411678 DOI: 10.18632/aging.202308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Zhou Y, Wen D, Wang J. Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis. Int J Mol Sci 2023;24. [PMID: 36675315 DOI: 10.3390/ijms24021801] [Reference Citation Analysis]
2 Wen D, Zhang H, Zhou Y, Wang J. The Molecular Mechanisms and Function of miR-15a/16 Dysregulation in Fibrotic Diseases. Int J Mol Sci 2022;23. [PMID: 36555676 DOI: 10.3390/ijms232416041] [Reference Citation Analysis]
3 Mei X, Zhang B, Zhao M, Lu Q. An update on epigenetic regulation in autoimmune diseases. J Transl Autoimmun 2022;5:100176. [PMID: 36544624 DOI: 10.1016/j.jtauto.2022.100176] [Reference Citation Analysis]
4 Yousefi H, Bahramy A, Zafari N, Delavar MR, Nguyen K, Haghi A, Kandelouei T, Vittori C, Jazireian P, Maleki S, Imani D, Moshksar A, Bitaraf A, Babashah S. Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer. BMC Cancer 2022;22:1282. [PMID: 36476410 DOI: 10.1186/s12885-022-10383-z] [Reference Citation Analysis]
5 Gibson F, Hanly A, Grbic N, Grunberg N, Wu M, Collard M, Alani RM. Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases. Clinic Rev Allerg Immunol 2022. [DOI: 10.1007/s12016-022-08956-8] [Reference Citation Analysis]
6 Pan W, Chen KJ, Huang YC. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C. Anticancer Drugs 2022;33:913-22. [PMID: 36136991 DOI: 10.1097/CAD.0000000000001381] [Reference Citation Analysis]
7 Hatmal MM, Al-hatamleh MAI, Olaimat AN, Alshaer W, Hasan H, Albakri KA, Alkhafaji E, Issa NN, Al-holy MA, Abderrahman SM, Abdallah AM, Mohamud R. Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects. Biomedicines 2022;10:1219. [DOI: 10.3390/biomedicines10061219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Yang L, Yang S, Ren C, Liu S, Zhang X, Sui A. Deciphering the roles of miR-16-5p in Malignant Solid Tumorsmalignant solid tumors. Biomed Pharmacother 2022;148:112703. [PMID: 35149384 DOI: 10.1016/j.biopha.2022.112703] [Reference Citation Analysis]
9 Wang X, Pham A, Kang L, Walker SA, Davidovich I, Iannotta D, TerKonda SP, Shapiro S, Talmon Y, Pham S, Wolfram J. Effects of Adipose-Derived Biogenic Nanoparticle-Associated microRNA-451a on Toll-like Receptor 4-Induced Cytokines. Pharmaceutics 2021;14:16. [PMID: 35056912 DOI: 10.3390/pharmaceutics14010016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Vaghf A, Khansarinejad B, Ghaznavi-Rad E, Mondanizadeh M. The role of microRNAs in diseases and related signaling pathways. Mol Biol Rep 2021. [PMID: 34718938 DOI: 10.1007/s11033-021-06725-y] [Reference Citation Analysis]
11 Szabo I, Muntean L, Crisan T, Rednic V, Sirbe C, Rednic S. Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAs. Biomedicines 2021;9:1471. [PMID: 34680587 DOI: 10.3390/biomedicines9101471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Tsou PS, Varga J, O'Reilly S. Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential. Nat Rev Rheumatol 2021;17:596-607. [PMID: 34480165 DOI: 10.1038/s41584-021-00683-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
13 Luzi L, Carruba M, Crialesi R, Da Empoli S, Dagani R, Lovati E, Nicolucci A, Berra CC, Cipponeri E, Vaccaro K, Lenzi A. Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture. Acta Diabetol 2021;58:919-27. [PMID: 33740123 DOI: 10.1007/s00592-021-01700-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]